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ABSTRACT
INTRODUCTION: Parkinson’s disease is a neurodegenerative disease affecting older age populations. There is variable
evidence of its relationship with hypertension. To date most of the studies have targeted orthostatic hypotension,
however, rare data regarding supine hypertension has been witnessed so far. This study aimed at determining the
association of supine hypertension with Parkinson’s disease.
Methodology: A retrospective observational study was conducted at the Department of Neurology, Pakistan Institute
of Medical Sciences, Islamabad. Medical records of 32 patients with Parkinson’s disease were reviewed. Data included
baseline, clinical and therapy information along with presence of supine hypertension. Ethical clearance was taken and
administrative permission was granted by HOD. Study outcome was measured in terms of relationship of supine
hypertension with Parkinson’s disease.
Results: Male gender (75.0%) and older age than 60 years (56.2%) was predominantly affected with PD. Almost one
third patients had known hypertension 9 (28.1%) out of which 7 (21.9%) are on ARBs. There were 5 (15.6%) patients
on beta blocker, 1 (3.1%) was having calcium chain blocker and 2 (6.2%) diuretics. Out of total 68.9% patients had
supine hypertension. Duration of PD was found greater in patients with supine hypertension.
Conclusion: Supine hypertension is significantly associated with Parkinson’s disease, especially found in patients with
longer duration of disease.
Keywords; Parkinson’s disease, supine hypertension, duration of PD.

INTRODUCTION
Parkinson’s disease is not very common but affected
patients have progressive decline in their quality of life
and became dependant fot activities of daily living.1.The
status of supine hypertension and its association with
clinical features of hypertension are still to be
elucidated in detail.2 The prevalence of this
neurodegenerative disorder is rising rapidly in older
ages affecting more than 1.7% of the population over
the age of 65 years.3 It is estimated that by 2030 the
current incidence of PD will double as the populations
age globally.4 The causes of PD are mostly not
well-known, which hampers the proper therapeutic
programs and preventive measures to combat
neurodegeneration. PD is a multifactorial brain
disorder. The inherited forms of PD account for only
10–15% of all cases, and the majority of PD cases are
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likely due to different combinations of environmental
exposures and genetic susceptibility.5-6 Possible
environmental exposures including alcohol intake,
coffee, vitamin E intake and use of nonsteroidal
anti-inflammatory drugs could reduce the PD risk;7-10
although, pesticide exposure and milk intake could
increase its risk.11-13 Nevertheless, at present, the
environmental risk factors for developing PD are still not
fully known. Hypertensive abnormalities can occur due
to autonomic dysfunction, even before the onset of the
classic motor symptoms of PD.14 In addition to
orthostatic and postprandial hypotension, PD patients
also experience nocturnal and supine hypertension,
which suggests that BP regulation is impaired to great
extent in these patients . The report by Tsukamoto
found that nocturnal hypertension exists in up to 64.9%
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of PD patients.15 In Pakistan , around 1 million elder
population is living with PD and the trend is on a rise.
Another local study estimated around half million
people afflicted with PD.16 There seems limited data on
the epidemiology of the disease, similarly, more deep
insight into the causes, prevention or interventions for
improving quality of life of these patients is required.
The current study is aimed at establishing the risk of
supine HTN in PD so that with early identification of
HTN, proper management can be started. We plan to
assess the association of supine hypertension and
Parkinson’s Disease in patients presenting to the
neurology clinic of a tertiary care level hospital.

taking calcium chain blocker whereas diuretics were
being taken by 2 (6.2%) . (Table 3) Supine
hypertension was present in a significant proportion of
PD cases in the current study 22 (68.7%) and this
signifies its association with PD.(Figure I) Supine
hypertension was found both in both genders (90.% vs
68.2%) and the difference in incidence could not be
proven statistically significant (p-value, 0.18). The
association of age distribution of PD patients and
supine hypertension was not significant. The greater
the duration of PD more isn the risk of supine
hypertension (3.8 versus 2.4 years), however, this was
borderline statistically significant (p-value, 0.09). Table
4

METHODOLOGY:

Table 1: Baseline characteristics

This retrospective observational study was conducted in
the Neurology Department, Pakistan Institute of
Medical Sciences. The medical records of PD patients
who came to the department over a period of 2 years
from 2018 to 2020 was reviewed. There were 32
patients whose medical information was complete and
they were selected in the study. The ethical clearance
was taken from the hospital ethics committee and
consent and permission of the head of the department
was taken to use the medical record of patients for this
research. The study parameters included the baseline
information of patients in terms of age and gender,
moreover clinical information was based on the
duration of disease, presentation and management of
patients. The presence of supine hypertension was
recorded. Data was analyzed in SPSS version 20.0 and
the categorical variables such as gender, clinical
presentation of hypertension, ARBs and ACBs, medical
therapy and supine hypertension were analyzed as
frequency and percentages. The continuous numerical
variables like age and duration of PD were measured as
mean and standard deviation. Further analysis was
done to associate the baseline and clinical parameters
with presence of supine hypertension using chi-square
in case of categorical variable and student’s t-test in
case of continuous numerical variables.

Table 2: Clinical presentation of patients

Table 3: Therapies given to patients

RESULTS:
In this study a total of 32 patients of Parkinson’s
Disease were enrolled. Males were in majority 24
(75.0%) and most of them were above 60 years of age
and females were 8 (25.0 %). The average age of
patients was 62.5 years. (Table 1) The mean duration
of the PD disease was 3.4 years. Nine (28.1%) had
known hypertensive whereas 7 (21.9%) were taking
ARBs. Moreover, none of the patients had taken ACE
inhibitors. (Table 2) There were 5 (15.6%) patients on
beta blocker therapy in this study. One (3.1%) was
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study when further analysis was done to see any
association between demographic and clinical features
of PD patients with presence of supine hypertension,
no significant variation was noted. Nonetheless, the
longer duration of PD was found to be related with
supine hypertension. There are few studies on the
mechanisms of supine hypertension. Theoretically,
supine hypertension could result from excessive cardiac
output or from inappropriately high systemic vascular
resistance.2 On the other hand many studies have
proven the link between orthostatichypotension and
Parkinson’s Disease.23 In brief, it can be argued that
males of older ages are more likely to get affected by
PD and supine hypertension is significantly related to
the condition. Moreover, the longer duration of PD has
been witnessed in the patients. The current study has
many advantages ,firstly it highlighted the significance
of early diagnosis of HTN in supine position when
autonomic disturbances and othostatic hypertension
hide its presence.Secondly, the quantification of
hypertension in PD patients is an additional advantage,
specially keeping in mind the lack of evidence on these
patients. One of the limitations was absence of long
term outcome of these patients and role of supine
hypertension on the overall condition and its response
to treatment. Further data on these missing loops need
to be gathered and disseminated.

Figure I: Supine Hypertension in the study
Table 4: Association of baseline and clinical
features with supine hypertension

DISCUSSION:
This study highlights a significant proportion of PD
patients having supine hypertension and proving an
association of the two conditions.As previous scientific
evidence suggests a controversy and no clear picture of
hypertension and PD this study validates some
investigator’s points and proofs regarding correlation of
hypertension with these patients.17 In this study almost
70.0% patients were found to have supine
hypertension, whereas their known condition was only
in one-third of this proportion. Goldstein DS and
colleagues in a previous study reported that pure
autonomic failure, multiple system atrophy and
Parkinson’s disease all featured supine hypertension,
which was equivalent in severity with essential
hypertension.18 Many others have also found presence
of supine hypertension in PD. A review study by Espay A
et al disclosed that autonomic dysfunction is present in
most of PD patients, this dysfunction is related to
hemodynamic abnormalities.2 Another study by
Kaufmann H and Goldstein DS also proved that supine
hypertension is related with autonomic dysfunction in
Parkinson’s disease.19 Another study by Berganzo K and
colleagues also confirmed the relationship of supine
hypertension and Parkinson’s Disease.20 This proves
and validates the findings of current study. Continued
with previous literature, in the present study male
gender and older age than 60 years was predominantly
affected by PD. The study by Goldstein DS had also
found male preponderance.18 Another study by Ejaz and
colleagues also witnessed male majority and elder ages
in PD.21 PD is an old age neurodegenerative disorder
which has been proven many times, moreover, male
affliction has also been witnessed.22 In the present
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CONCLUSION:
Supine hypertension is significantly associated with
Parkinson’s disease, especially when the duration of
disease is already long. In this study male gender and
older ages were found more afflicted with the disease.
Further studies from other parts of country and
worldwide are needed to validate the findings of this
study. Long term outcome and role of supine
hypertension towards drug therapy response also
needs to be elucidated.
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